Why the study?
Does complete ablation of the slow pathway compared to partial ablation affect the fast pathway effective refractory period in patients with AVNRT?
Does complete ablation of the slow pathway compared to partial ablation affect the fast pathway effective refractory period in patients with AVNRT?
Complete, but not partial, ablation of the slow pathway in AVNRT results in shortening of the fast pathway effective refractory period, suggesting electrotonic inhibition of the fast pathway by the slow pathway.
Answers are grounded in this paper and cite their sources.
Complete slow pathway ablation may differentially affect fast pathway properties versus partial ablation in AVNRT; leaves open effects on recurrence and optimal endpoints.
INTRODUCTION: The purpose of this study was to prospectively compare the effects of complete and partial ablation of slow pathway function on the fast pathway effective refractory period (ERP). METHODS AND RESULTS: The subjects were 20 patients (mean age 43 +/- 13 years) with atrioventricular nodal reentrant tachycardia (AVNRT), no structural heart disease, and easily inducible AVNRT. Autonomic blockade was achieved with propranolol (0.2 mg/kg) and atropine (0.04 mg/kg). After elimination of AVNRT and during autonomic blockade, the presence of residual slow pathway function was determined by the presence of a single AV nodal echo and/or dual AV nodal physiology. After autonomic blockade and before ablation, the mean fast pathway ERP was 319 +/- 44 msec and the mean slow pathway ERP was 251 +/- 31 msec. After slow pathway ablation and during autonomic blockade, 7 patients had residual slow pathway function and 13 did not. Complete loss of slow pathway function was associated with a shortening of the fast pathway ERP from 334 +/- 35 msec to 300 +/- 62 msec (P < 0.01), while the fast pathway ERP did not change significantly in patients with residual slow pathway function (291 +/- 29 msec vs 303 +/- 38 msec, respectively; P = 0.08). A shortening of 30 msec or more in the fast pathway ERP was observed in 11 of 13 patients who did not have residual slow pathway function, compared to 0 of 7 patients with residual slow pathway function (P < 0.001). CONCLUSION: Shortening of the fast pathway ERP after successful ablation of AVNRT is dependent upon complete loss of slow pathway function. This observation is consistent with electrotonic inhibition of the fast pathway by the slow pathway.
No takes yet. Share an insight, caveat, or question.
Strickberger et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: